Publications by authors named "Judith Knapp"

Claim this Profile
E
Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259).
Heidi S Donovan, Susan M Sereika, Lari B Wenzel, Robert P Edwards, Judith E Knapp

J Clin Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer.
Vinata B Lokeshwar, Daley S Morera, Sarrah L Hasanali, Travis J Yates, Marie C Hupe, Judith Knapp

Clin Cancer Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Web-based symptom management for women with recurrent ovarian cancer: a pilot randomized controlled trial of the WRITE Symptoms intervention.
Heidi S Donovan, Sandra E Ward, Susan M Sereika, Judith E Knapp, Paula R Sherwood

J Pain Symptom Manage· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered expression of farnesyl pyrophosphate synthase in prostate cancer: evidence for a role of the mevalonate pathway in disease progression?
Tilman Todenhöfer, Jörg Hennenlotter, Ursula Kühs, Valentina Gerber, Georgios Gakis, Judith Knapp

World J Urol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence.
Judith S Knapp, Soum D Lokeshwar, Ulrich Vogel, Jörg Hennenlotter, Christian Schwentner

World J Urol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.
Travis J Yates, Judith Knapp, Miguel Gosalbez, Soum D Lokeshwar, Christopher S Gomez

Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrence.
Stefan Aufderklamm, Jörg Hennenlotter, Tilman Todenhoefer, Georgios Gakis, David Schilling, Judith Knapp

World J Urol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissue.
Sandra Waalkes, Perikles Simon, Jörg Hennenlotter, Judith Knapp, Hossein Tezval

Oncol Rep· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer.
Mario W Kramer, Roozbeh Golshani, Axel S Merseburger, Judith Knapp, Alfredo Garcia

Eur Urol· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronic acid and HYAL-1 in prostate biopsy specimens: predictors of biochemical recurrence.
Christopher S Gomez, Pablo Gomez, Judith Knapp, Merce Jorda, Mark S Soloway

J Urol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic regulation of HYAL-1 hyaluronidase expression. identification of HYAL-1 promoter.
Vinata B Lokeshwar, Pablo Gomez, Mario Kramer, Judith Knapp, Melissa A McCornack

J Biol Chem· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer.
Axel S Merseburger, Mario W Kramer, Jörg Hennenlotter, Perikles Simon, Judith Knapp

Prostate· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis